<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01579500</url>
  </required_header>
  <id_info>
    <org_study_id>PC12MIMV0005</org_study_id>
    <secondary_id>20120007154</secondary_id>
    <secondary_id>suyon 2011-131</secondary_id>
    <nct_id>NCT01579500</nct_id>
  </id_info>
  <brief_title>Neuropathic Pain Study With Botulinum Toxin A in Spinal Cord Injury Patients</brief_title>
  <official_title>The Effect of Botulinum Toxin A in Post Spinal Cord Injury Neuropathic Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catholic University of Korea Saint Paul's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Health Insurance Service Ilsan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medy-Tox</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Catholic University of Korea Saint Paul's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether botulinum toxin A is effective in the
      treatment of neuropathic pain in spinal cord injury patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neuropathic pain remains a significant cause of life quality deterioration. This study
      includes spinal cord injury patients with refractory chronic neuropathic pain and
      investigates whether injection with botulinum toxin A improves pain scores.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analogue scale</measure>
    <time_frame>4 weeks after intervention</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Spinal Cord Injury</condition>
  <condition>Neuropathic Pain</condition>
  <arm_group>
    <arm_group_label>botulinum toxin A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Botulinum toxin type A</intervention_name>
    <description>Subcutaneous injection of botulinum toxin type A</description>
    <arm_group_label>botulinum toxin A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>Subcutaneous injection of normal saline</description>
    <arm_group_label>normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  more than twenty years of age

          -  paraplegic or tetraplegic due to cervical and thoracic spinal cord injury

          -  more than 12 months since spinal cord injury and ASIA impairment scale unchanged for
             more than 6 months

          -  persistence of neuropathic pain for more than three months or remission and recurrence
             of neuropathic pain for more than six months

          -  a pain score of 40mm or more on the visual analogue scale

        Exclusion Criteria:

          -  neuropathic pain caused by confounding factors other than spinal cord injury

          -  contraindicated for botulinum toxin type A

          -  a change in pain medication one month prior to study enrollment

          -  a condition involving neuromuscular junction (Ex. Eaton Lambert disease, myasthenia
             gravis)

          -  person who received botulinum toxin type A within three months prior to study
             enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Catholic University Saint Paul's Hospital; National Health Insurance Corporation Ilsan Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2012</study_first_submitted>
  <study_first_submitted_qc>April 16, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2012</study_first_posted>
  <last_update_submitted>April 23, 2013</last_update_submitted>
  <last_update_submitted_qc>April 23, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Catholic University of Korea Saint Paul's Hospital</investigator_affiliation>
    <investigator_full_name>Myung Eun, Chung</investigator_full_name>
    <investigator_title>clinical assistant proffessor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Neuralgia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>onabotulinumtoxinA</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

